The US Monkeypox Testing Market was Valued at $5 Million at the End of 2022; the US Government to Invest in the Future-Ready Diagnostics Segment to Minimize the Future Monkeypox Cases - Arizton

CHICAGO, March 1, 2023 /PRNewswire/ -- Arizton's latest research report states that the US monkeypox testing market was valued at $5 million by 2022-2025. The growing trends in the U.S. monkeypox testing market are ongoing research activities, the rapid development of rapid testing methods, and rapidly growing commercial laboratory-developed monkeypox testing. The abrupt global expansion of the monkeypox virus has increased the demand for monkeypox diagnostics. Due to the increased market rivalry, large worldwide firms and other prominent players compete for a footprint in the market and come up with more product launches. Increasing surveillance of monkeypox cases in the US drives product launches.

Download the Free Sample Report Now: https://www.arizton.com/request-sample/3729

In partnership with state, local, and expert stakeholders, the US government has identified critical areas of research that will advance understanding of the US and global monkeypox outbreak and enable it to respond to the current outbreak and prevent future outbreaks effectively. The US government allocated $140 million to support high-priority projects, leveraging ongoing efforts and collaboration with institutions. The US government will develop serologic surveys, observational epidemiological and clinical studies, molecular epidemiology, ecological research, global education, and the development of early-stage healthcare measures provided.

THE U.S. MONKEYPOX TESTING MARKET REPORT SCOPE

Download the Free Sample Report Now: https://www.arizton.com/request-sample/3729

The U.S. has a strong pipeline in the monkeypox diagnostic segment. National Institutes of Health (NIH), National Institute of Biomedical Imaging and Bioengineering (NIBIB), Department of Defense (DOD), and more institutions have invested in advanced monkeypox diagnostics. The research results are to be released in the first half of 2023. The country is investing in the future-ready diagnostics segment, which will help the region defend against future cases.

The Southern region accounted for the largest U.S. monkeypox testing market share at 33.58%. The perception that the response to the monkeypox virus in the South has lacked coordination has rekindled familiar concerns about recent state policies. States like California have followed the CDC's recommendation to prioritize gay and bisexual men in outreach, vaccination, and treatment for monkeypox. Such states have declared a public health emergency and initiated aggressive, targeted vaccination campaigns. Although California has the highest number of cases, Florida, Georgia, and Texas are home to robust gay communities and have just over a quarter of the country's confirmed monkeypox cases.

CUSTOMIZE YOUR REPORT NOW:

If our report does not include the information you are searching for, you may contact us to have a report tailored to your specific business needs https://www.arizton.com/customize-report/3729

VENDOR INSIGHTS

Market players are focused on developing new testing methods for monkeypox detection. The competition among the vendors is high as there is a wide opportunity for diagnostic players to enter this market. The growing popularity of rapid tests for monkeypox and advances in PCR technology has offered significant growth to this market. The ongoing research activities for diagnosing and treating monkeypox and the insights from research studies drive market growth in the US. Moreover, vendors are exclusively focused on broadening their monkeypox diagnostics portfolio to cater to the exponential surge in demand for monkeypox tests. There has been a growth in PCR kit launches since the outbreak in the region.

Download the Free Sample Report Now: https://www.arizton.com/request-sample/3729

Key Company Profiles

• Abbott
• F. Hoffmann-La Roche
• Qiagen
• Thermo Fisher Scientific

Other Prominent Vendors

• Alpha Diagnostic
• AtliaBiosystems
• Applied DNA Sciences
• BioGX
• BIONEER
• CERTEST BIOTEC
• Co-Diagnostics
• CorDx
• Creative Biogene
• Elabscience Biotechnology
• LABNOVATION TECHNOLOGIES
• Seegene

Laboratory-Developed Monkeypox Tests

• Aegis Sciences
• ARUP Laboratories
• Apostle Diagnostics
• California Department of Public Health
• CDR Companies
• CirrusDx
• Clinical Reference Laboratory
• Devlab Bio
• Discover Labs
• Integrity Laboratories
• Laboratory Corporation of America Holdings
• Madison Core Laboratories
• Mako Medical Laboratories
• Mayo Clinic
• Quest Diagnostics
• RapidBio
• Shepard Health
• Sonic Healthcare
• US BioTek Laboratories
• UW Virology Laboratory

Download the Free Sample Report Now: https://www.arizton.com/request-sample/3729

MARKET SEGMENTATION

Type

• PCR
• Lateral Flow Assay
• Others

End-User

• Laboratories
• Hospitals & Clinics
• Others

Region

• The U.S.
• Southern
• Western
• Northeast
• Central

KNOW MORE ABOUT THE MARKET: https://www.arizton.com/market-reports/us-monkeypox-testing-market

TABLE OF CONTENT

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY TYPE

4.3.2 MARKET SEGMENTATION BY END-USER

4.3.3 MARKET SEGMENTATION BY REGION

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

6 PREMIUM INSIGHTS

6.1 OVERVIEW

7 MARKET AT A GLANCE

8 INTRODUCTION

8.1 OVERVIEW

9 MARKET OPPORTUNITIES & TRENDS

9.1 ONGOING US MONKEYPOX RESEARCH ACTIVITIES

9.2 GROWING DEVELOPMENT OF RAPID TESTING METHODS

9.3 RAPIDLY GROWING COMMERCIAL LABORATORY-DEVELOPED MONKEYPOX TESTING

10 MARKET GROWTH ENABLERS

10.1 INCREASING PRODUCT LAUNCHES

10.2 ADVANCES IN PCR TECHNOLOGY

10.3 MONKEYPOX ERADICATION UNLIKELY TO CONTINUE IN US

11 MARKET RESTRAINTS

11.1 GROWING ACCESS TO VACCINATION AGAINST MONKEYPOX

11.2 MONKEYPOX CASES ARE IN A SHARP DECLINE

11.3 POTENTIAL RISK OF FALSE MONKEYPOX TEST RESULTS

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW

12.1.1 INSIGHTS BY TYPE

12.1.2 INSIGHTS BY END-USER

12.1.3 INSIGHTS BY REGION

12.2 FIVE FORCES ANALYSIS

12.2.1 THREAT OF NEW ENTRANTS

12.2.2 BARGAINING POWER OF SUPPLIERS

12.2.3 BARGAINING POWER OF BUYERS

12.2.4 THREAT OF SUBSTITUTES

12.2.5 COMPETITIVE RIVALRY

13 TESTING TYPE

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 POLYMERASE CHAIN REACTION (PCR)

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.4 LATERAL FLOW ASSAY

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.5 OTHER

13.5.1 MARKET OVERVIEW

13.5.2 MARKET SIZE & FORECAST

14 END-USER

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 LABORATORIES

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.4 HOSPITALS & CLINICS

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.5 OTHERS

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

15 REGION

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 SOUTHERN

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.4 WESTERN

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.5 NORTHEAST

15.5.1 MARKET OVERVIEW

15.5.2 MARKET SIZE & FORECAST

15.6 CENTRAL

15.6.1 MARKET OVERVIEW

15.6.2 MARKET SIZE & FORECAST

16 COMPETITIVE LANDSCAPE

16.1 COMPETITION OVERVIEW

16.2 MARKET SHARE ANALYSIS

16.2.1 ABBOTT

16.2.2 F. HOFFMANN-LA ROCHE

16.2.3 QIAGEN

16.2.4 THERMO FISHER SCIENTIFIC

17 KEY COMPANY PROFILES

17.1 ABBOTT

17.1.1 BUSINESS OVERVIEW

17.1.2 PRODUCT OFFERINGS

17.1.3 KEY STRATEGIES

17.1.4 KEY STRENGTHS

17.1.5 KEY OPPORTUNITIES

17.2 F. HOFFMANN-LA ROCHE

17.3 QIAGEN

17.4 THERMO FISHER SCIENTIFIC

18 OTHER PROMINENT VENDORS

18.1 ALPHA DIAGNOSTIC

18.1.1 BUSINESS OVERVIEW

18.1.2 PRODUCT OFFERINGS

18.2 ATILABIOSYSTEMS

18.3 APPLIED DNA SCIENCES

18.4 BIOGX

18.5 BIONEER

18.6 CERTEST BIOTEC

18.7 CO-DIAGNOSTICS

18.8 CORDX

18.9 CREATIVE BIOGENE

18.10 ELABSCIENCE BIOTECHNOLOGY

18.11 LABNOVATION TECHNOLOGIES

18.12 SEEGENE

19 LABORATORY-DEVELOPED MONKEYPOX TESTS

19.1 AEGIS SCIENCES

19.1.1 BUSINESS OVERVIEW

19.1.2 PRODUCT OFFERINGS

19.2 ARUP LABORATORIES

19.3 APOSTLE DIAGNOSTICS

19.4 CALIFORNIA DEPARTMENT OF PUBLIC HEALTH

19.5 CDR COMPANIES

19.6 CIRRUSDX

19.7 CLINICAL REFERENCE LABORATORY

19.8 DEVLAB BIO

19.9 DISCOVER LABS

19.10 INTEGRITY LABORATORIES

19.11 LABORATORY CORPORATION OF AMERICA HOLDINGS

19.12 MADISON CORE LABORATORIES

19.13 MAKO MEDICAL LABORATORIES

19.14 MAYO CLINIC

19.15 QUEST DIAGNOSTICS

19.16 RAPIDBIO

19.17 SHEPARD HEALTH

19.18 SONIC HEALTHCARE

19.19 US BIOTEK LABORATORIES

19.2 UW VIROLOGY LABORATORY

20 REPORT SUMMARY

20.1 KEY TAKEAWAYS

20.2 STRATEGIC RECOMMENDATIONS

21 QUANTITATIVE SUMMARY

21.1 MARKET BY TYPE

21.2 MARKET BY END-USER

21.3 MARKET BY REGION

22 APPENDIX

22.1 ABBREVIATIONS

CHECK OUT SOME OF THE TOP-SELLING RESEARCH-RELATED REPORTS:

Europe Monkeypox Testing Market - The Europe monkeypox testing market size was valued at USD 18.33 million in 2022. The market will register a CAGR of (85.48) % from 2022 to 2025.

In Vitro Diagnostics Market - The global in vitro diagnostics market size crossed USD 105.23 billion in 2022, growing at a CAGR of 3.26%. The low-volume sample analysis, automation, high-throughput analysis, rapid analysis times, small footprint, low cost, portability, and disposability are key trends in the IVD market.

HIV Rapid Test Kits Market - The global HIV rapid test kits market size was valued at USD 1.437 billion in 2022, growing at a CAGR of 2.70%. In recent years, the significant patient population in the country has gone through routine medical checkups, which includes HIV test. It increases the knowledge about HIV testing and cares in the country and propels the market growth.

COVID-19 Rapid Antigen Test Kits Market - The COVID-19 rapid antigen tests market is expected to reach $743.07 million by 2027. Rapid antigen tests are currently authorized on nasal or nasopharyngeal swab specimens placed directly into the immunoassay's extraction buffer or reagent. The currently available rapid antigen tests include point-of-care (POC) and laboratory-based tests, as well as self-tests performed at home. They are commercially available to people of any age.

ABOUT US:   

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.  

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.  

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.  

CONTACT US

Call: +1-312-235-2040 
        +1 302 469 0707 
Mail: [email protected]    
Contact Us: https://www.arizton.com/contact-us   
Blog: https://www.arizton.com/blog    
Website: https://www.arizton.com/

Photo: https://mma.prnewswire.com/media/2011962/US_MONKEYPOX_MARKET.jpg
Logo: https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg

SOURCE Arizton Advisory & Intelligence